Modern medicine is practiced just as much in the laboratory as in a hospital ward. Laboratory tests of human samples – such as for identifying and measuring viruses, bacteria, and microscopic components of the human body – are essential for determining a diagnosis, selecting the best course of treatment, and dispensing the right dose of medicine. The quality of a hospital or doctor’s office is therefore highly dependent on the quality of its laboratory. But how can one ensure that methods and equipment yield reliable results?||
Laboratory quality control is the answer. And it was invented in Norway.||
In the 1950s, Professor Lorentz Eldjarn conducted the world’s first successful experiments using a standardized control serum for internal quality control at his laboratory at Oslo University Hospital, Rigs hospital et. Thirteen years later, the company SE RO was born, and the world’s first commercially available control serum, Zero norm, was launched.||
SE RO is still a pioneer in quality control materials. It has a steadily growing portfolio of standard and tailor-made products that are used around the globe for quality control of lab tests and calibration of equipment. The global market for laboratory quality control is currently some USD 905 million. Thanks to Norwegian research, doctors and researchers worldwide can trust their lab results.||
The world’s first standardized control serum for quality control at laboratories was invented in Norway. SE RO|| Fighting cancer that has spread to the bones||
Some types of cancer are more difficult to treat than others. When cancer has spread to the bones, for example, there are few alternatives. Available treatments have major side effects and are of varying efficacy. Fortunately, a Norwegian company has found a way to slow bone metastases.||
Building on research conducted at Oslo University Hospital, Radium hospital et, Al, Zeta has developed a cancer drug based on radium-223, a radioactive isotope. While radium treatment of cancer was widespread in the past, it has more or less been replaced by alternatives with fewer side effects. Al zeta’s breakthrough is a targeted drug that is highly precise and has a short half-life, thereby minimizing side effects. The drug was launched under the name Alpharadin and is now called Xor Vigo.||
Some 1.3 million men are diagnosed with prostate cancer each year. Xor Vigo is used to treating prostate cancer when cancer has spread to the bones and is approved for use in both Europe and the US. Founded in 1997, Al zeta was acquired by the multinational company Bayer in 2011. However, production and research activities are still located in Norway, where work is being done to develop similar methods for treating breast cancer and lung cancer.||
Norwegian invention isolates DNA from cells||
In 1977, Professor John Ugelstad at the Norwegian University of Science and Technology managed to solve a problem that had been puzzling researchers for years: creating a set of microscopic beads of the same size. The professor and his team then went on to make these uniform beads magnetizable and found that they could be used to separate biological materials with extremely high precision.||
The company Danial was founded shortly after to further develop and commercialize the technology. The beads were given the name Diana's beads and have since been used in isolating and removing cancer cells, isolating DNA, tissue-typing in connection with organ transplantation, and HIV research.||
Diana's beads are still produced in Lille strum, near Oslo, and are used in roughly 80 percent of all oncological sequencing in Europe.||
You must be logged in to post a comment.